FDA Inspection 1105851 — Evonik Rexim S.A.S.
The FDA completed an inspection of Evonik Rexim S.A.S. on September 6, 2019 in Ham. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 6, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ham (France)